Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             120 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparative study of the serological response to Japanese encephalitis vaccine in HIV-infected and uninfected Thai children Chokephaibulkit, Kulkanya
 2010
 28 Supplement 4 p. 3563-3566
4 p.
 artikel
2 A comparative study on the safety and immunogenicity of purified duck embryo cell vaccine (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab) Ashwathnarayana, Doddabele Hanumantaiah
 2009
 28 Supplement 4 p. 148-151
4 p.
 artikel
3 Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model Sorensen, Maria R.
 2010
 28 Supplement 4 p. 6757-6764
8 p.
 artikel
4 Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: Different effects on cellular and humoral immunity Ganguly, Sumita
 2010
 28 Supplement 4 p. 1300-1309
10 p.
 artikel
5 Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children Passwell, Justen H.
 2010
 28 Supplement 4 p. 2231-2235
 artikel
6 A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity Schabowsky, Rich-Henry
 2009
 28 Supplement 4 p. 512-522
11 p.
 artikel
7 A preliminary study of chemo- and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens Saraya, Abhinbhen
 2010
 28 Supplement 4 p. 4553-4557
5 p.
 artikel
8 A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6–35 months Esposito, Susanna
 2010
 28 Supplement 4 p. 6137-6144
8 p.
 artikel
9 Are hard-to-reach populations being reached with immunization services? Findings from the 2005 Papua New Guinea national immunization coverage survey Toikilik, Steven
 2010
 28 Supplement 4 p. 4673-4679
7 p.
 artikel
10 Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Levy, Vivian
 2010
 28 Supplement 4 p. 5947-5951
5 p.
 artikel
11 A systematic review of measures for reducing injection pain during adult immunization Hogan, Mary-Ellen
 2010
 28 Supplement 4 p. 1514-1521
8 p.
 artikel
12 A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice Block, Olivia K.T.
 2010
 28 Supplement 4 p. 8085-8094
10 p.
 artikel
13 A universal anti-HIV-1 Tat epitope vaccine that is fully synthetic and self-adjuvanting Goldstein, Gideon
 2010
 28 Supplement 4 p. 1008-1014
7 p.
 artikel
14 Baculovirus as an avian influenza vaccine vector: Differential immune responses elicited by different vector forms Chen, Chi-Yuan
 2010
 28 Supplement 4 p. 7644-7651
8 p.
 artikel
15 BoLA-DR peptide binding pockets are fundamental for foot-and-mouth disease virus vaccine design in cattle Baxter, R.
 2009
 28 Supplement 4 p. 28-37
10 p.
 artikel
16 Carbohydrate moieties as vaccine candidates: Meeting summary Lucas, A.H.
 2010
 28 Supplement 4 p. 1121-1131
11 p.
 artikel
17 CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine Cao, Jun
 2010
 28 Supplement 4 p. 7514-7522
9 p.
 artikel
18 Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses Rodenburg, Gerwin D.
 2010
 28 Supplement 4 p. 1391-1396
6 p.
 artikel
19 Comparison of long-term humoral memory development after immunisation against Neisseria meningitidis B or diphtheria toxoid Cruz, Simone C.
 2010
 28 Supplement 4 p. 6841-6846
6 p.
 artikel
20 Complex cytokine profiles induced by BCG vaccination in UK infants Lalor, Maeve K.
 2010
 28 Supplement 4 p. 1635-1641
7 p.
 artikel
21 Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model Whaley, Melissa J.
 2010
 28 Supplement 4 p. 3071-3075
5 p.
 artikel
22 Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model Fang, Rui
 2010
 28 Supplement 4 p. 1803-1807
5 p.
 artikel
23 Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination Balicer, Ran D.
 2010
 28 Supplement 4 p. 5591-5596
6 p.
 artikel
24 Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina Giglio, Norberto D.
 2010
 28 Supplement 4 p. 2302-2310
9 p.
 artikel
25 Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50–90 years Weinberger, Birgit
 2010
 28 Supplement 4 p. 3511-3515
5 p.
 artikel
26 Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate Posadas-Herrera, Guillermo
 2010
 28 Supplement 4 p. 7939-7946
8 p.
 artikel
27 Development and immunogenicity of a recombinant pseudorabies virus expressing Sj26GST and SjFABP from Schistosoma japonicum Wei, Feng
 2010
 28 Supplement 4 p. 5161-5166
6 p.
 artikel
28 Development of an 8-plex Luminex assay to detect swine cytokines for vaccine development: Assessment of immunity after porcine reproductive and respiratory syndrome virus (PRRSV) vaccination Lawson, Steven
 2010
 28 Supplement 4 p. 5356-5364
9 p.
 artikel
29 Development of novel lipidated analogs of picroside as vaccine adjuvants: Acylated analogs of picroside-II elicit strong Th1 and Th2 response to ovalbumin in mice Kumar, H.M. Sampath
 2010
 28 Supplement 4 p. 8327-8337
11 p.
 artikel
30 Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper Chandran, Dev
 2009
 28 Supplement 4 p. 132-139
8 p.
 artikel
31 Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI® Vilaplana, C.
 2010
 28 Supplement 4 p. 1106-1116
11 p.
 artikel
32 Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix Heldens, J.G.M.
 2010
 28 Supplement 4 p. 6989-6996
8 p.
 artikel
33 Editorial Board 2010
 28 Supplement 4 p. CO2-
1 p.
 artikel
34 Editorial Board 2010
 28 Supplement 4 p. CO2-
1 p.
 artikel
35 Editorial Board 2010
 28 Supplement 4 p. CO2-
1 p.
 artikel
36 Editorial Board 2010
 28 Supplement 4 p. CO2-
1 p.
 artikel
37 Editorial Board 2010
 28 Supplement 4 p. CO2-
1 p.
 artikel
38 Editorial Board 2010
 28 Supplement 4 p. CO2-
1 p.
 artikel
39 Effects of astragalus polysaccharides on immunologic function of erythrocyte in chickens infected with infectious bursa disease virus Jiang, Junbing
 2010
 28 Supplement 4 p. 5614-5616
3 p.
 artikel
40 Effects of maternal plasmid GHRH treatment on offspring growth Khan, Amir S.
 2010
 28 Supplement 4 p. 1905-1910
6 p.
 artikel
41 Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens Shim, Doo-Hee
 2010
 28 Supplement 4 p. 2311-2317
7 p.
 artikel
42 Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method Rückinger, Simon
 2010
 28 Supplement 4 p. 5012-5016
5 p.
 artikel
43 Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10 Da’dara, Akram A.
 2010
 28 Supplement 4 p. 1310-1317
8 p.
 artikel
44 Enhanced humoral and cellular immune responses after sublingual immunization against human papillomavirus 16 L1 protein with adjuvants Cho, Hee-Jeong
 2010
 28 Supplement 4 p. 2598-2606
9 p.
 artikel
45 Enhancement of IL-10 bioactivity using an IL-10 peptide-based vaccine exacerbates Leishmania major infection and improves airway inflammation in mice Zhou, Gang
 2010
 28 Supplement 4 p. 1838-1846
9 p.
 artikel
46 Evaluation of hepatic changes and local and systemic immune responses in goats immunized with recombinant Peroxiredoxin (Prx) and challenged with Fasciola hepatica Mendes, Ricardo E.
 2010
 28 Supplement 4 p. 2832-2840
9 p.
 artikel
47 Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep Dungu, Baptiste
 2010
 28 Supplement 4 p. 4581-4587
7 p.
 artikel
48 Experimental iron-inactivated Pasteurella multocida A: 1 vaccine adjuvanted with bacterial DNA is safe and protects chickens from fowl cholera Herath, Chitra
 2010
 28 Supplement 4 p. 2284-2289
6 p.
 artikel
49 Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits Heldens, J.G.M.
 2010
 28 Supplement 4 p. 8125-8131
7 p.
 artikel
50 Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: Waning of infancy-induced immune memory? Posfay-Barbe, Klara M.
 2010
 28 Supplement 4 p. 4356-4361
6 p.
 artikel
51 Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism Gong, Zhaohui
 2010
 28 Supplement 4 p. 4052-4058
7 p.
 artikel
52 Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(−/−) mice against lethal bluetongue infection Calvo-Pinilla, Eva
 2009
 28 Supplement 4 p. 437-445
9 p.
 artikel
53 High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects Potsch, D.V.
 2010
 28 Supplement 4 p. 1447-1450
4 p.
 artikel
54 HSP65 serves as an immunogenic carrier for a diabetogenic peptide P277 inducing anti-inflammatory immune response in NOD mice by nasal administration Liang, Jin
 2010
 28 Supplement 4 p. 3312-3317
6 p.
 artikel
55 Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein Murata, Yoshihiko
 2010
 28 Supplement 4 p. 6242-6246
5 p.
 artikel
56 Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate Kelly, Eileen P.
 2010
 28 Supplement 4 p. 3030-3037
8 p.
 artikel
57 Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220 Overton, E.T.
 2010
 28 Supplement 4 p. 5597-5604
8 p.
 artikel
58 Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia Souza, Alessandra R.
 2010
 28 Supplement 4 p. 1117-1120
4 p.
 artikel
59 Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: Attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV Van Rompay, Koen K.A.
 2010
 28 Supplement 4 p. 1481-1492
12 p.
 artikel
60 Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland King Jr., James C.
 2010
 28 Supplement 4 p. 7737-7742
6 p.
 artikel
61 Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains Lee, Vernon J.
 2010
 28 Supplement 4 p. 6852-6857
6 p.
 artikel
62 Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV Zhang, Rongxin
 2010
 28 Supplement 4 p. 5114-5127
14 p.
 artikel
63 Intranasal immunization with Leish-111f induces IFN-γ production and protects mice from Leishmania major infection Sakai, Shun-ichi
 2010
 28 Supplement 4 p. 2207-2213
 artikel
64 In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6 von Teichman, Beate F.
 2010
 28 Supplement 4 p. 6505-6517
13 p.
 artikel
65 IRX-2 increases the T cell-specific immune response to protein/peptide vaccines Naylor, Paul H.
 2010
 28 Supplement 4 p. 7054-7062
9 p.
 artikel
66 Liposomal gD ectodomain (gD1–306) vaccine protects against HSV2 genital or rectal infection of female and male mice Olson, K.
 2009
 28 Supplement 4 p. 548-560
13 p.
 artikel
67 Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response Wang, Danan
 2010
 28 Supplement 4 p. 3134-3142
9 p.
 artikel
68 Low serum serotype-specific pneumococcal antibody concentrations in young children with Haemophilus influenzae serotype b (Hib) vaccine failure Ladhani, Shamez
 2010
 28 Supplement 4 p. 4440-4444
5 p.
 artikel
69 Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenza Lin, Jianping
 2010
 28 Supplement 4 p. 5669-5675
7 p.
 artikel
70 MALVAC 2009: Progress and Challenges in Development of Whole Organism Malaria Vaccines for Endemic Countries, 3–4 June 2009, Dakar, Senegal Pinder, M.
 2010
 28 Supplement 4 p. 4695-4702
8 p.
 artikel
71 Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: Longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier Deauvieau, Florence
 2009
 28 Supplement 4 p. 576-582
7 p.
 artikel
72 Meningococcal serogroup C polysaccharide specific memory B cells, directly enumerated by labeled polysaccharide, are not affected by age at vaccination Henneken, Maren
 2010
 28 Supplement 4 p. 2097-2103
7 p.
 artikel
73 Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza Liljebjelke, Karen A.
 2010
 28 Supplement 4 p. 4430-4437
8 p.
 artikel
74 Murine neutralizing antibody response and toxicity to synthetic peptides derived from E1 and E2 proteins of hepatitis C virus El-Awady, Mostafa K.
 2010
 28 Supplement 4 p. 8338-8344
7 p.
 artikel
75 Needle-free jet injection of small doses of Japanese encephalitis DNA and inactivated vaccine mixture induces neutralizing antibodies in miniature pigs and protects against fetal death and mummification in pregnant sows Imoto, Jun-ichi
 2010
 28 Supplement 4 p. 7373-7380
8 p.
 artikel
76 Neem leaf glycoprotein matures myeloid derived dendritic cells and optimizes anti-tumor T cell functions Goswami, Shyamal
 2010
 28 Supplement 4 p. 1241-1252
12 p.
 artikel
77 Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7 Adachi, Katsuyuki
 2010
 28 Supplement 4 p. 2810-2817
8 p.
 artikel
78 Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice Yuan, Lin
 2010
 28 Supplement 4 p. 4402-4410
9 p.
 artikel
79 Persistence of mucosal and systemic immune responses following sublingual immunization Negri, Donatella R.M.
 2010
 28 Supplement 4 p. 4175-4180
6 p.
 artikel
80 Pharmacoeconomic evaluation of 10- and 13-valent pneumococcal conjugate vaccines Chuck, Anderson W.
 2010
 28 Supplement 4 p. 5485-5490
6 p.
 artikel
81 Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin Smith, Larry R.
 2010
 28 Supplement 4 p. 2565-2572
8 p.
 artikel
82 Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities Yu, Yongxin
 2010
 28 Supplement 4 p. 3635-3641
7 p.
 artikel
83 Porcine lactoferrin administration enhances peripheral lymphocyte proliferation and assists infectious bursal disease vaccination in native chickens Hung, Che-Ming
 2010
 28 Supplement 4 p. 2895-2902
8 p.
 artikel
84 Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom Andrews, Nick
 2010
 28 Supplement 4 p. 7215-7220
6 p.
 artikel
85 Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer Krashias, George
 2010
 28 Supplement 4 p. 2482-2489
8 p.
 artikel
86 Promiscuous T-cell epitopes of Plasmodium merozoite surface protein 9 (PvMSP9) induces IFN-γ and IL-4 responses in individuals naturally exposed to malaria in the Brazilian Amazon Lima-Junior, J.C.
 2010
 28 Supplement 4 p. 3185-3191
7 p.
 artikel
87 Protection of BALB/c mice against Brucella melitensis 16M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein Al-Mariri, Ayman
 2010
 28 Supplement 4 p. 1766-1770
5 p.
 artikel
88 Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination Hwang, Seon Do
 2010
 28 Supplement 4 p. 2957-2964
8 p.
 artikel
89 Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice Little, S.F.
 2010
 28 Supplement 4 p. 934-939
6 p.
 artikel
90 Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines Wysocki, J.
 2010
 28 Supplement 4 p. 7779-7786
8 p.
 artikel
91 Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: A transcriptomics analysis of adjuvanted vaccines Reemers, Sylvia S.
 2010
 28 Supplement 4 p. 6351-6360
10 p.
 artikel
92 Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1 Sealy, R.
 2010
 28 Supplement 4 p. 6749-6756
8 p.
 artikel
93 Rotavirus enterotoxin NSP4 has mucosal adjuvant properties Kavanagh, Owen V.
 2010
 28 Supplement 4 p. 3106-3111
6 p.
 artikel
94 SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model Sharma, Rajesh K.
 2010
 28 Supplement 4 p. 5794-5802
9 p.
 artikel
95 Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and booster immunization Li, Guifan
 2010
 28 Supplement 4 p. 4215-4223
9 p.
 artikel
96 Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults Frey, Sharon E.
 2010
 28 Supplement 4 p. 6367-6373
7 p.
 artikel
97 Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster Mills, Richard
 2010
 28 Supplement 4 p. 4204-4209
6 p.
 artikel
98 Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany Kieninger, Dorothee M.
 2010
 28 Supplement 4 p. 4192-4203
12 p.
 artikel
99 Selection and identification of malaria vaccine target molecule using bioinformatics and DNA vaccination Shuaibu, M.N.
 2010
 28 Supplement 4 p. 6868-6875
8 p.
 artikel
100 Serine proteases of Leishmania amazonensis as immunomodulatory and disease-aggravating components of the crude LaAg vaccine de Matos Guedes, Herbert Leonel
 2010
 28 Supplement 4 p. 5491-5496
6 p.
 artikel
101 Seroconversion following incomplete human rabies postexposure prophylaxis Robertson, Kis
 2010
 28 Supplement 4 p. 6523-6526
4 p.
 artikel
102 Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006–2009 Srifeungfung, Somporn
 2010
 28 Supplement 4 p. 3440-3444
5 p.
 artikel
103 Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection Rudraraju, Rajeev
 2010
 28 Supplement 4 p. 4997-5004
8 p.
 artikel
104 Standardization and validation of assays determining cellular immune responses against influenza Gijzen, Karlijn
 2010
 28 Supplement 4 p. 3416-3422
7 p.
 artikel
105 T cell-based functional cDNA library screening identified SEC14-like 1a carboxy-terminal domain as a negative regulator of human immunodeficiency virus replication Urano, Emiko
 2010
 28 Supplement 4 p. B68-B74
nvt p.
 artikel
106 The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infection Crum-Cianflone, Nancy F.
 2010
 28 Supplement 4 p. 7583-7588
6 p.
 artikel
107 The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice Chen, Xiaohua
 2010
 28 Supplement 4 p. 3913-3919
7 p.
 artikel
108 The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis Farmaki, Evangelia
 2010
 28 Supplement 4 p. 5109-5113
5 p.
 artikel
109 The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000–2007 Bettinger, Julie A.
 2010
 28 Supplement 4 p. 2130-2136
7 p.
 artikel
110 The immunogenicity of intradermal influenza vaccination in COPD patients Chuaychoo, Benjamas
 2010
 28 Supplement 4 p. 4045-4051
7 p.
 artikel
111 The need for quadrivalent vaccine against seasonal influenza Belshe, Robert B.
 2010
 28 Supplement 4 p. D45-D53
nvt p.
 artikel
112 The smallpox vaccine induces an early neutralizing IgM response Moyron-Quiroz, Juan E.
 2009
 28 Supplement 4 p. 140-147
8 p.
 artikel
113 Th2-polarisation of cellular immune memory to neonatal pertussis vaccination White, Olivia J.
 2010
 28 Supplement 4 p. 2648-2652
5 p.
 artikel
114 Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE Trigo, Joelma
 2010
 28 Supplement 4 p. 3333-3340
8 p.
 artikel
115 Type 2 immune-inducing helminth vaccination maintains protective efficacy in the setting of repeated parasite exposures Hübner, Marc P.
 2010
 28 Supplement 4 p. 1746-1757
12 p.
 artikel
116 Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: Meeting at the Crossroads Madore, Dace V.
 2010
 28 Supplement 4 p. 4539-4547
9 p.
 artikel
117 Variable-number tandem repeat markers for identification of Brucella abortus 82 and 75/79-AV vaccine strains Kulakov, Yury K.
 2010
 28 Supplement 4 p. F41-F45
nvt p.
 artikel
118 Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4 Veronesi, Eva
 2010
 28 Supplement 4 p. 1397-1403
7 p.
 artikel
119 VP5-deficient mutant virus induced protection against challenge with very virulent infectious bursal disease virus of chickens Qin, Liting
 2010
 28 Supplement 4 p. 3735-3740
6 p.
 artikel
120 Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses Bian, Guanglin
 2009
 28 Supplement 4 p. 187-194
8 p.
 artikel
                             120 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland